Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study

Journal of Human Hypertension

Volumn 16, Issue 12, 2002, Pages 865-873

  Ragot, Stephanie ^a   Ezzaher, A ^b   Meunier, A ^b   Poterre, M ^b   Bourkaib, R ^b   Herpin, D ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b GLAXOSMITHKLINE   (France)

Author keywords

Perindopril; Self blood pressure measurement; Telmisartan; Trough effect

Indexed keywords

ANTIHYPERTENSIVE AGENT; PERINDOPRIL; TELMISARTAN;

ADULT; AGED; AMBULATORY MONITORING; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CLINICAL OBSERVATION; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; COUGHING; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FEASIBILITY STUDY; FEMALE; HOME MONITORING; HUMAN; INTERMETHOD COMPARISON; LABORATORY AUTOMATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PARALLEL DESIGN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF EXAMINATION; SELF MONITORING; SPHYGMOMANOMETER; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE DETERMINATION; DIASTOLE; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; PERINDOPRIL; PROSPECTIVE STUDIES; RANDOM ALLOCATION; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATISTICS; SYSTOLE; TREATMENT OUTCOME;

EID: 0036962546     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001494     Document Type: Article

References (29)

1. Abe H et al. Relation of office and home blood pressure to left ventricular hypertrophy and performance in patients with hypertension. High Blood Press 1992; 1: 279-285.
2. Ohkubo T et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: A population-based observation in Ohasama, Japan. J Hypertens 1998; 16: 971-975.
3. Nesbitt SD et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh study. Am J Hypertens 1997; 10: 1270-1280.
4. James JD, Pickering TG, Yees LS. Reproducibility of average ambulatory, home and clinic pressures. Hypertension 1998; 11: 545-549.
5. Sakuma M et al. Reproducibility of home blood pressure measurements over a one-year period. Am J Hypertens 1997; 10: 798-803.
6. Carnahan JE, Nugent CA. The effects of self-monitoring by patients on the control of hypertension. Am J Med Sci 1975; 269: 69-73.
7. Zarnke K, Feagan B, Mahon J, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens 1997; 10: 58-67.
8. Edmonds D et al. Does self-measurement of blood pressure improve patient compliance in hypertension? J Hypertens 1985; 3 (Suppl): S31-S34.
9. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens 1996; 9: 1-11.
10. Soghikan K et al. Home blood pressure monitoring: Effect on use of medical services and medical care costs. Med Care 1992; 30: 855-865.
11. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1: 55-61.
12. Asmar R, Zanchetti A. Guidelines for the use of self-blood pressure monitoring: A summary report of the First International Consensus Conference. Groupe Evaluation & Measure of the French Society of Hypertension. J Hypertens 2000; 18: 493-508.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of measurement. Lancet 1986; I: 307-310.
14. Neutel JM et al. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension. Am J Ther 1999; 6: 161-166.
15. Smith DH, Matzek KM, Kempthorne-Rawson J. Dose response and safety of telmisartan in patients with mild to moderate hypertension. J Clin Pharmacol 2000; 40: 1380-1390.
16. Smith DH, Neutel JM, Morgenstern P. Once daily telmisartan compared with enalapril in the treatment of hypertension. Adv Ther 1998; 15: 229-240.
17. Neutel JM, Smith DH, Reilly PA. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension. Int J Clin Pract 1999; 53: 175-178.
18. Karlberg BE, Lins LE, Hermansson K. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. TEES Study Group. J Hypertens 1999; 17: 293-302.
19. Mallion JM, Siché JP, Lacoucière Y and the Telmisartan Blood Pressure Monitoring Group. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension. J Hum Hypertens 1999; 13: 657-664.
20. Lacourcière Y et al. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit 1998; 3: 295-302.
21. Lacourcière Y et al. Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy. J Hum Hypertens 2001; 15: 763-770.
22. Dickerson JE et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes. Lancet 1999; 353: 2008-2013
23. Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: Feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000; 13: 632-639.
24. Brook RD. Home blood pressure: Accuracy is independent of monitoring schedules. An J Hypertens 2000; 13: 625-631.
25. Kjeldsen SE et al. Hypertension optimal treatment (HOT) study. Home blood pressure in treated hypertensive subjects. Hypertension 1998; 31: 1014-1020.
26. Parati G, Omboni S, Mancia G. Difference between office and ambulatory blood pressure and response to antihypertensive treatment. J Hypertens 1996; 14: 791-797.
27. Ima Y et al. Usefulness of home blood pressure measurements in assessing the effect of treatment in a single-blind placebo-controlled open trial. J Hypertens 2001; 19: 179-185.
28. Bobrie G et al. Is isolated home hypertension as opposed to isolated office hypertension a sign of greater cardiovascular risk? Arch Intern Med 2001; 161: 2205-2211.
29. Karlberg BE, Lins LE, Hermansson K, for the TEES Study Group. Efficacy and safety of telmisartan, a selective AT1 receptor antagonist, compared with enalapril in elderly patients with primary hypertension. J Hypertens 1999; 17: 293-302.